|
21TP
Open-state structure of veratridine-activated human Nav1.7
提交 2025-12-24
|
构建体不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 A
1–1988(1988 aa)
|
未记录
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
Y01 CHOLESTEROL HEMISUCCINATE × 4
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 8
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 2
A1E26 Veratridine × 1
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.4
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.00 Å
|
|
21TQ
The structure of Nav1.7 with veratridine standing near the IFM motif (site I)
提交 2025-12-24
|
构建体不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 A
1–1988(1988 aa)
|
未记录
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 8
A1E26 Veratridine × 1
Y01 CHOLESTEROL HEMISUCCINATE × 4
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 2
P3X (5E,17R,20S)-23-amino-20-hydroxy-14,20-dioxo-15,19,21-trioxa-20lambda~5~-phosphatricos-5-en-17-yl hexadecanoate × 1
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.4
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 2.70 Å
|
|
5EK0
Human Nav1.7-VSD4-NavAb in complex with GX-936.
提交 2015-11-03
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
实验方法不同
实验环境不同
结构质量不同
|
Assembly 1
信息不足
同源多聚体;蛋白 × 4
PDB 声明:tetrameric
|
链 A
1527–1559(33 aa)
链 A
1581–1622(42 aa)
链 B
1527–1559(33 aa)
链 B
1581–1622(42 aa)
链 C
1527–1559(33 aa)
链 C
1581–1622(42 aa)
链 D
1527–1559(33 aa)
链 D
1581–1622(42 aa)
|
未记录
|
PX4 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 21
5P2 3-cyano-4-[2-[2-(1-ethylazetidin-3-yl)pyrazol-3-yl]-4-(trifluoromethyl)phenoxy]-~{N}-(1,2,4-thiadiazol-5-yl)benzenesulfonamide × 4
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 5.4;277 K;2.2 ammonium sulfate, 100 mM sodium citrate pH 5.4
|
分辨率 3.53 Å
R-free 0.272
|
|
6J8G
Structure of human voltage-gated sodium channel Nav1.7 in complex with auxiliary beta subunits, huwentoxin-IV and saxitoxin (Y1755 up)
提交 2019-01-19
|
构建体不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 A
1–1988(1988 aa)
|
未记录
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7
9SL [(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,9,10-tetrahydro-3H,8H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate × 1
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.4
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.20 Å
|
|
6J8H
Structure of human voltage-gated sodium channel Nav1.7 in complex with auxiliary beta subunits, huwentoxin-IV and saxitoxin (Y1755 down)
提交 2019-01-19
|
构建体不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 A
1–1988(1988 aa)
|
未记录
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7
9SL [(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,9,10-tetrahydro-3H,8H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate × 1
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.4
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.20 Å
|
|
6J8I
Structure of human voltage-gated sodium channel Nav1.7 in complex with auxiliary beta subunits, ProTx-II and tetrodotoxin (Y1755 up)
提交 2019-01-19
|
构建体不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 A
1–1988(1988 aa)
|
未记录
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7
9SR (1R,5R,6R,7R,9S,11S,12S,13S,14S)-3-amino-14-(hydroxymethyl)-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1~7,11~.0~1,6~]tetradec-3-ene-5,9,12,13,14-pentol (non-preferred name) × 1
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.4
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.20 Å
|
|
6J8J
Structure of human voltage-gated sodium channel Nav1.7 in complex with auxiliary beta subunits, ProTx-II and tetrodotoxin (Y1755 down)
提交 2019-01-19
|
构建体不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 A
1–1988(1988 aa)
|
未记录
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7
9SR (1R,5R,6R,7R,9S,11S,12S,13S,14S)-3-amino-14-(hydroxymethyl)-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1~7,11~.0~1,6~]tetradec-3-ene-5,9,12,13,14-pentol (non-preferred name) × 1
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.4
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.20 Å
|
|
6N4Q
CryoEM structure of Nav1.7 VSD2 (actived state) in complex with the gating modifier toxin ProTx2
提交 2018-11-20
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
信息不足
异源复合物;蛋白 × 12
PDB 声明:dodecameric
|
链 A
747–777(31 aa)
链 A
811–842(32 aa)
链 B
747–777(31 aa)
链 B
811–842(32 aa)
链 C
747–777(31 aa)
链 C
811–842(32 aa)
链 D
747–777(31 aa)
链 D
811–842(32 aa)
|
未记录
|
未记录非水小分子
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 8;10 mM Tris pH 8.0, 100 mM NaCl, 0.06% FA3, 0.1 mg/ml POPC:POPE:POPG mixed at molar ratio 3:1:1
cryo-EM玻璃化条件
冷冻剂 ETHANE;Apply 3 uL, blot 2.5s. Ted Pella 595 filter paper.
|
分辨率 3.60 Å
|
|
6N4R
CryoEM structure of Nav1.7 VSD2 (deactived state) in complex with the gating modifier toxin ProTx2
提交 2018-11-20
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
信息不足
异源复合物;蛋白 × 12
PDB 声明:dodecameric
|
链 A
747–777(31 aa)
链 A
811–842(32 aa)
链 B
747–777(31 aa)
链 B
811–842(32 aa)
链 C
747–777(31 aa)
链 C
811–842(32 aa)
链 D
747–777(31 aa)
链 D
811–842(32 aa)
|
未记录
|
未记录非水小分子
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 8;10 mM Tris pH 8.0, 100 mM NaCl, 0.06% FA3, 0.1 mg/ml POPC:POPE:POPG mixed at molar ratio 3:1:1
cryo-EM玻璃化条件
冷冻剂 ETHANE;Apply 3 uL, blot 2.5s. Ted Pella 595 filter paper.
|
分辨率 4.20 Å
|
|
6NT3
Cryo-EM structure of a human-cockroach hybrid Nav channel.
提交 2019-01-28
|
聚集状态不同
配体/离子不同
结构质量不同
|
Assembly 1
信息不足
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
1500–1631(132 aa)
|
未记录
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4
Y01 CHOLESTEROL HEMISUCCINATE × 1
76F (7E,21R,24S)-27-amino-24-hydroxy-18,24-dioxo-19,23,25-trioxa-24lambda~5~-phosphaheptacos-7-en-21-yl (9Z,12E)-octadeca-9,12-dienoate × 4
LHG 1,2-DIPALMITOYL-PHOSPHATIDYL-GLYCEROLE × 1
AJP Digitonin × 1
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.40 Å
|
|
6VXO
NaChBac-Nav1.7VSDII chimera in nanodisc
提交 2020-02-22
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
实验环境不同
|
Assembly 1
信息不足
同源多聚体;蛋白 × 4
PDB 声明:tetrameric
|
链 A
817–832(16 aa)
链 C
817–832(16 aa)
链 D
817–832(16 aa)
链 E
817–832(16 aa)
|
未记录
|
POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 12
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 8
cryo-EM玻璃化条件
冷冻剂 ETHANE;blot for 5 seconds before plunging
|
分辨率 3.50 Å
|
|
6W6O
NaChBac-Nav1.7VSDII chimera and HWTX-IV complex
提交 2020-03-17
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
信息不足
异源复合物;蛋白 × 8
PDB 声明:octameric
|
链 A
817–832(16 aa)
链 D
817–832(16 aa)
链 F
817–832(16 aa)
链 H
817–832(16 aa)
|
未记录
|
POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 12
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 10
cryo-EM玻璃化条件
冷冻剂 ETHANE;Blotted for 5 seconds before plunging
|
分辨率 3.20 Å
|
|
7K48
Structure of NavAb/Nav1.7-VS2A chimera trapped in the resting state by tarantula toxin m3-Huwentoxin-IV
提交 2020-09-15
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
信息不足
异源复合物;蛋白 × 8
PDB 声明:octameric
|
链 A
739–779(41 aa)
链 A
805–830(26 aa)
链 B
739–779(41 aa)
链 B
805–830(26 aa)
链 C
739–779(41 aa)
链 C
805–830(26 aa)
链 D
739–779(41 aa)
链 D
805–830(26 aa)
|
突变:R398A,L506A,M513V
突变:R398A,L506A,M513V
突变:R398A,L506A,M513V
突变:R398A,L506A,M513V
突变:R398A,L506A,M513V
突变:R398A,L506A,M513V
突变:R398A,L506A,M513V
突变:R398A,L506A,M513V
|
未记录非水小分子
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE;Blot for 2.5-4.0 seconds before plunging
|
分辨率 3.60 Å
|
|
7W9K
Cryo-EM structure of human Nav1.7-beta1-beta2 complex at 2.2 angstrom resolution
提交 2021-12-09
|
构建体不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 A
1–1988(1988 aa)
|
未记录
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
P5S O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine × 3
Y01 CHOLESTEROL HEMISUCCINATE × 6
9Z9 (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en × 1
NA SODIUM ION × 1
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 15
1PW (2S,3R,4E)-2-(acetylamino)-3-hydroxyoctadec-4-en-1-yl dihydrogen phosphate × 1
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 5
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.4
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 2.20 Å
|
|
7W9L
Cryo-EM structure of human Nav1.7(E406K)-beta1-beta2 complex
提交 2021-12-10
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
实验环境不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 A
1–1988(1988 aa)
|
突变:E406K
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
P5S O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine × 3
Y01 CHOLESTEROL HEMISUCCINATE × 6
9Z9 (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en × 1
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 14
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 5
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.4
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.50 Å
|
|
7W9M
Cryo-EM structure of human Nav1.7(E406K) in complex with auxiliary beta subunits, ProTx-II and tetrodotoxin (S6IV pi helix conformer)
提交 2021-12-10
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 A
1–1988(1988 aa)
|
突变:E406K
|
9SR (1R,5R,6R,7R,9S,11S,12S,13S,14S)-3-amino-14-(hydroxymethyl)-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1~7,11~.0~1,6~]tetradec-3-ene-5,9,12,13,14-pentol (non-preferred name) × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
P5S O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine × 1
Y01 CHOLESTEROL HEMISUCCINATE × 5
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 1
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.4
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.00 Å
|
|
7W9P
Cryo-EM structure of human Nav1.7(E406K) in complex with auxiliary beta subunits, huwentoxin-IV and saxitoxin (S6IV pi helix conformer)
提交 2021-12-10
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 A
1–1988(1988 aa)
|
突变:E406K
|
9SL [(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,9,10-tetrahydro-3H,8H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
P5S O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine × 3
Y01 CHOLESTEROL HEMISUCCINATE × 6
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 13
1PW (2S,3R,4E)-2-(acetylamino)-3-hydroxyoctadec-4-en-1-yl dihydrogen phosphate × 1
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 5
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.4
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 2.90 Å
|
|
7W9T
Cryo-EM structure of human Nav1.7(E406K) in complex with auxiliary beta subunits, huwentoxin-IV and saxitoxin (S6IV alpha helix conformer)
提交 2021-12-10
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 A
1–1988(1988 aa)
|
突变:E406K
|
9SL [(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,9,10-tetrahydro-3H,8H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
P5S O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine × 2
Y01 CHOLESTEROL HEMISUCCINATE × 5
9Z9 (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en × 1
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 14
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 5
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.4
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.00 Å
|
|
7XM9
Cryo-EM structure of human NaV1.7/beta1/beta2-XEN907
提交 2022-04-25
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
结构质量不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 A
1–1977(1977 aa)
|
突变:W1150R
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
G2E (7~{R})-1'-pentylspiro[6~{H}-furo[3,2-f][1,3]benzodioxole-7,3'-indole]-2'-one × 1
6OU [(2~{R})-1-[2-azanylethoxy(oxidanyl)phosphoryl]oxy-3-hexadecanoyloxy-propan-2-yl] (~{Z})-octadec-9-enoate × 1
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.22 Å
|
|
7XMF
Cryo-EM structure of human NaV1.7/beta1/beta2-Nav1.7-IN2
提交 2022-04-25
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
结构质量不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 A
1–1977(1977 aa)
|
突变:W1150R
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
G2W 3-[[4-[3-(4-fluoranyl-2-methyl-phenoxy)azetidin-1-yl]pyrimidin-2-yl]amino]-~{N}-methyl-benzamide × 1
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.07 Å
|
|
7XMG
Cryo-EM structure of human NaV1.7/beta1/beta2-TCN-1752
提交 2022-04-25
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
结构质量不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 A
1–1977(1977 aa)
|
突变:W1150R
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
G4I (1~{Z})-~{N}-[2-methyl-3-[(~{E})-[6-[4-[[4-(trifluoromethyloxy)phenyl]methoxy]piperidin-1-yl]-1~{H}-1,3,5-triazin-2-ylidene]amino]phenyl]ethanimidic acid × 1
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.09 Å
|
|
7XVE
Human Nav1.7 mutant class-I
提交 2022-05-21
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
结构质量不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 A
1–1988(1988 aa)
|
突变:E156K,G779R,L866F,T870M,A874F,V947F,M952F,V953F,V1438I,V1439F,G1454C
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7
Y01 CHOLESTEROL HEMISUCCINATE × 1
CLR CHOLESTEROL × 4
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 18
1PW (2S,3R,4E)-2-(acetylamino)-3-hydroxyoctadec-4-en-1-yl dihydrogen phosphate × 1
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 6
P5S O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine × 1
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 2.70 Å
|
|
7XVF
Nav1.7 mutant class2
提交 2022-05-22
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
结构质量不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 A
1–1988(1988 aa)
|
突变:E156K,G779R,L866F,T870M,A874F,V947F,M952F,V953F,V1438I,V1439F,G1454C
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7
Y01 CHOLESTEROL HEMISUCCINATE × 5
CLR CHOLESTEROL × 1
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 17
1PW (2S,3R,4E)-2-(acetylamino)-3-hydroxyoctadec-4-en-1-yl dihydrogen phosphate × 1
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 6
P5S O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine × 1
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 2.80 Å
|
|
8F0P
Structure of VSD4-NaV1.7-NaVPas channel chimera bound to the hybrid inhibitor GNE-1305
提交 2022-11-03
|
构建体不同
聚集状态不同
配体/离子不同
结构质量不同
|
Assembly 1
信息不足
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
1501–1630(130 aa)
|
未记录
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3
PEE 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine × 5
Y01 CHOLESTEROL HEMISUCCINATE × 1
X7L N-[6-(cyclopentylmethoxy)-1,3-benzothiazol-2-yl]-4-{[(1S,2S)-2-(dimethylamino)cyclohexyl]amino}-2-fluorobenzene-1-sulfonamide × 1
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 2.20 Å
|
|
8F0Q
Structure of VSD4-NaV1.7-NaVPas channel chimera bound to the acylsulfonamide inhibitor GDC-0310
提交 2022-11-03
|
构建体不同
聚集状态不同
配体/离子不同
结构质量不同
|
Assembly 1
信息不足
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
1501–1630(130 aa)
|
未记录
|
BMA beta-D-mannopyranose × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
X7R 5-cyclopropyl-4-({1-[(1S)-1-(3,5-dichlorophenyl)ethyl]piperidin-4-yl}methoxy)-2-fluoro-N-(methanesulfonyl)benzamide × 1
PEE 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine × 5
Y01 CHOLESTEROL HEMISUCCINATE × 1
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 2.50 Å
|
|
8F0R
Structure of VSD4-NaV1.7-NaVPas channel chimera bound to the arylsulfonamide inhibitor GNE-3565
提交 2022-11-03
|
构建体不同
聚集状态不同
配体/离子不同
结构质量不同
|
Assembly 1
信息不足
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
1501–1630(130 aa)
|
未记录
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
X7W 5-chloro-4-({(1S,2S,4S)-2-(dimethylamino)-4-[3-(trifluoromethyl)phenyl]cyclohexyl}amino)-2-fluoro-N-(pyrimidin-4-yl)benzene-1-sulfonamide × 1
PEE 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine × 2
Y01 CHOLESTEROL HEMISUCCINATE × 1
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 2.90 Å
|
|
8F0S
Structure of VSD4-NaV1.7-NaVPas channel chimera bound to the hybrid inhibitor GNE-9296
提交 2022-11-03
|
构建体不同
聚集状态不同
配体/离子不同
结构质量不同
|
Assembly 1
信息不足
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 A
1501–1630(130 aa)
片段:Chimeric construct of human Nav1.7 VSD4 and the NavPaS channel from American cockroach Periplaneta americana
|
未记录
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4
X80 5-chloro-4-(cyclopentylmethoxy)-N-(4-{[(1S,2S)-2-(dimethylamino)cyclohexyl]amino}-2-fluorobenzene-1-sulfonyl)-2-fluorobenzamide × 1
PEE 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine × 1
Y01 CHOLESTEROL HEMISUCCINATE × 1
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.10 Å
|
|
8G1A
Cryo-EM structure of Nav1.7 with CBD
提交 2023-02-01
|
构建体不同
聚集状态不同
配体/离子不同
结构质量不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 A
1–1988(1988 aa)
|
未记录
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
P0T cannabidiol × 2
P5S O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine × 2
Y01 CHOLESTEROL HEMISUCCINATE × 5
9Z9 (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en × 1
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 13
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 4
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 2.80 Å
|
|
8I5B
Structure of human Nav1.7 in complex with bupivacaine
提交 2023-01-24
|
构建体不同
聚集状态不同
配体/离子不同
结构质量不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 A
1–1988(1988 aa)
|
未记录
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7
P5S O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine × 1
Y01 CHOLESTEROL HEMISUCCINATE × 6
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 6
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 5
OJ0 Levobupivacaine × 1
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 2.70 Å
|
|
8I5G
Structure of human Nav1.7 in complex with PF-05089771
提交 2023-01-25
|
构建体不同
聚集状态不同
配体/离子不同
结构质量不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 A
1–1988(1988 aa)
|
未记录
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
Y01 CHOLESTEROL HEMISUCCINATE × 2
9Z9 (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en × 1
T70 PF-05089771 × 1
NA SODIUM ION × 1
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 8
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 5
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 2.70 Å
|
|
8I5X
Structure of human Nav1.7 in complex with Vinpocetine
提交 2023-01-26
|
构建体不同
聚集状态不同
配体/离子不同
结构质量不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 A
1–1988(1988 aa)
|
未记录
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
P5S O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine × 1
Y01 CHOLESTEROL HEMISUCCINATE × 5
9Z9 (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en × 1
T7F Vinpocetine × 1
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 11
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 5
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 2.90 Å
|
|
8I5Y
Structure of human Nav1.7 in complex with vixotrigine
提交 2023-01-26
|
构建体不同
聚集状态不同
配体/离子不同
结构质量不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 A
1–1988(1988 aa)
|
未记录
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
P5S O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine × 1
Y01 CHOLESTEROL HEMISUCCINATE × 4
9Z9 (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en × 1
TB4 Vixotrigine × 1
NA SODIUM ION × 1
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 14
1PW (2S,3R,4E)-2-(acetylamino)-3-hydroxyoctadec-4-en-1-yl dihydrogen phosphate × 1
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 5
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 2.60 Å
|
|
8J4F
Structure of human Nav1.7 in complex with Hardwickii acid
提交 2023-04-19
|
构建体不同
聚集状态不同
配体/离子不同
结构质量不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 A
1–1988(1988 aa)
|
未记录
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
UK0 (4~{a}~{R},5~{S},6~{R},8~{a}~{R})-5-[2-(furan-3-yl)ethyl]-5,6,8~{a}-trimethyl-3,4,4~{a},6,7,8-hexahydronaphthalene-1-carboxylic acid × 1
Y01 CHOLESTEROL HEMISUCCINATE × 3
9Z9 (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en × 1
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 10
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 4
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.00 Å
|
|
8S9B
Cryo-EM structure of Nav1.7 with LCM
提交 2023-03-27
|
构建体不同
聚集状态不同
配体/离子不同
结构质量不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 A
1–1988(1988 aa)
|
未记录
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4
LQO lacosamide × 2
P5S O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine × 2
Y01 CHOLESTEROL HEMISUCCINATE × 4
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 8
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 3
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 2.90 Å
|
|
8S9C
Cryo-EM structure of Nav1.7 with CBZ
提交 2023-03-27
|
构建体不同
聚集状态不同
配体/离子不同
结构质量不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 A
1–1988(1988 aa)
|
未记录
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
N6W benzo[b][1]benzazepine-11-carboxamide × 1
P5S O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine × 3
Y01 CHOLESTEROL HEMISUCCINATE × 5
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 9
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 4
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.20 Å
|
|
8THG
Cryo-EM structure of Nav1.7 with RLZ
提交 2023-07-16
|
构建体不同
聚集状态不同
配体/离子不同
结构质量不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 A
1–1988(1988 aa)
|
未记录
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
657 6-(trifluoromethoxy)-1,3-benzothiazol-2-amine × 1
Y01 CHOLESTEROL HEMISUCCINATE × 3
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 6
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 1
P5S O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine × 1
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 2.90 Å
|
|
8THH
Cryo-EM structure of Nav1.7 with LTG
提交 2023-07-16
|
构建体不同
聚集状态不同
配体/离子不同
结构质量不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 A
1–1988(1988 aa)
|
未记录
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
IYJ (6M)-6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine × 2
Y01 CHOLESTEROL HEMISUCCINATE × 4
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 6
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 3
P5S O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine × 1
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 2.70 Å
|
|
8XMM
Voltage-gated sodium channel Nav1.7 variant M9
提交 2023-12-27
|
构建体不同
聚集状态不同
配体/离子不同
结构质量不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 A
1–1988(1988 aa)
|
未记录
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
CLR CHOLESTEROL × 1
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 9
1PW (2S,3R,4E)-2-(acetylamino)-3-hydroxyoctadec-4-en-1-yl dihydrogen phosphate × 1
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 6
P5S O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine × 1
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 2.89 Å
|
|
8XMN
Voltage-gated sodium channel Nav1.7 variant M2
提交 2023-12-27
|
构建体不同
聚集状态不同
配体/离子不同
结构质量不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 A
1–1988(1988 aa)
|
未记录
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 5
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 3
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.37 Å
|
|
8XMO
Voltage-gated sodium channel Nav1.7 variant M4
提交 2023-12-27
|
构建体不同
聚集状态不同
配体/离子不同
结构质量不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 A
1–1988(1988 aa)
|
未记录
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 7
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 5
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.39 Å
|
|
8YHZ
The co-crystal structure of the Fab fragment of Ab-1080 with NaV1.7 VSDII peptide
提交 2024-02-28
|
构建体不同
聚集状态不同
配体/离子不同
实验方法不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 P
764–774(11 aa)
|
未记录
|
未记录非水小分子
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;291.15 K;0.2M potassium thiocyanate,
25% W/V Polyethylene glycol 3,350
|
分辨率 1.62 Å
R-free 0.210
|
|
9ITI
Nav1.7 with mutations that eliminate beta1 binding
提交 2024-07-20
|
构建体不同
聚集状态不同
配体/离子不同
结构质量不同
|
Assembly 1
其他组合
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
1–1988(1988 aa)
|
未记录
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
P5S O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine × 2
NA SODIUM ION × 1
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 10
1PW (2S,3R,4E)-2-(acetylamino)-3-hydroxyoctadec-4-en-1-yl dihydrogen phosphate × 1
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 5
Y01 CHOLESTEROL HEMISUCCINATE × 4
9Z9 (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en × 1
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 2.92 Å
|